PPA
LYRA

Parametric Portfolio Associates’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Parametric Portfolio Associates’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-339
Closed -$197K – 3584
2021
Q1 		$197K Sell
339
-389
-53% -$243K ﹤0.01% 3885
2020
Q4 		$415K Buy
728
+294
+68% +$166K ﹤0.01% 3456
2020
Q3 		$243K Buy
434
+192
+79% +$119K ﹤0.01% 3575
2020
Q2 		$137K Buy
+242
New +$177K ﹤0.01% 3719

Other funds holding LYRA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Parametric Portfolio Associates's LYRA Position: Q2 2021 in Review

Parametric Portfolio Associates sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2021, closing a stake of 339 shares — an estimated $197K sold.

Parametric Portfolio Associates first reported a position in LYRA in Q2 2020 and held it in 4 quarters. The position peaked at $415K in Q4 2020. 44 funds tracked by Wall St. Rank hold LYRA as of Q2 2021.

  • Parametric Portfolio Associates reported no remaining LYRA THERAPEUTICS INC position as of Q2 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 339 LYRA THERAPEUTICS INC shares in Q2 2021, an estimated $197K.
  • Parametric Portfolio Associates first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 4 quarters.
  • Parametric Portfolio Associates's LYRA THERAPEUTICS INC position peaked at $415K in Q4 2020.
  • 44 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2021.

Based on Parametric Portfolio Associates's 13F filing for Q2 2021, filed 13 Aug 2021.